Streetbeat News

Earnings

AVAV

AeroVironment projects its FY24 adjusted EPS to be between $2.69 and $2.83, compared to the estimated $2.73. The company also forecasts revenue to be in the range of $700M to $710M, versus the estimated $700.833M.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:14 pm

WISH

ContextLogic (NASDAQ:WISH) reported Q4 2023 earnings with a GAAP EPS of $(2.820), missing the $(2.660) estimate, and sales of $53.000M, slightly below the $53.060M estimate. This represents a 56.91% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:12 pm

EKSO

Ekso Bionics shares are trading higher following the announcement of mixed Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:11 pm

AVAV

AeroVironment (NASDAQ:AVAV) reported Q3 2024 adjusted EPS of $0.630, surpassing the $0.330 estimate, with sales of $186.600M exceeding the $170.625M forecast. This represents a 38.84% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:11 pm

SFIX

Stitch Fix shares dropped following the announcement of disappointing Q2 financial results and lower than expected revenue guidance for Q3 and FY24.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:10 pm

EOSE

Eos Energy Enterprises (NASDAQ:EOSE) reported Q4 earnings with an EPS of $-0.16, beating estimates by 36.0% against an expected $-0.25. Revenue increased by $3.93 million from the same period last year. Despite beating EPS estimates last quarter, the share price dropped by 25.0% the following day. Historical performance shows variability in meeting EPS and revenue estimates.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 9:10 pm

STXS

Stereotaxis (AMEX:STXS) reported its Q4 earnings with an EPS of $-0.07, matching the estimated EPS but missing on revenue by $2.74 million compared to the same period last year. The company's past earnings performance shows a pattern of missing EPS estimates, which previously led to a 3.0% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 9:10 pm

EKSO

Ekso Bionics Holdings (NASDAQ:EKSO) reported Q4 earnings with an EPS of $-0.22, missing estimates by -100.0% against an expected $-0.11. Revenue increased by $1.30 million from the previous year. The company had previously beaten EPS estimates in Q3 2023, which led to a 6.0% share price increase the following day.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 9:10 pm

PAY

Paymentus shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:09 pm

EKSO

Ekso Bionics Holdings reported Q4 2023 GAAP EPS of $(0.220), missing the $(0.110) estimate, but sales of $4.847M exceeded the $4.773M estimate, marking a 36.50% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:09 pm